Wall Street Divided After Key Inflation Reading

The Nasdaq's four-day win streak is in jeopardy today

Deputy Editor
Jan 12, 2023 at 12:02 PM
facebook X logo linkedin

Stocks are a mixed bag midday, despite this morning's encouraging consumer price index (CPI). Even amid the signs that inflation may be cooling, the Nasdaq Composite's (IXIC) four-day winning streak is in jeopardy. The Dow Jones Industrial Average (DJI), meanwhile, is up triple digits, while the S&P 500 Index (SPX) is marginally higher, with both indexes climbing out of the red this morning.

Investors are hoping that optimistic inflation readings will compel the Federal Reserve to ease off the scale of interest rate hikes. Against this backdrop, the Cboe Volatility Index (VIX) has slipped below 20 for the first time in over three weeks.

Continue reading for more on today's market, including: 

  • This software stock is one of our top picks for 2023.
  • Analyst turns bearish on 2 streaming stocks.
  • Plus, Vodafone's c-suite shakeup; BigBear.ai's massive contract; and Oramed Pharmaceuticals clinical trial slip.

Midday Market Stats January 122023

U.S.-listed shares of telecom giant Vodafone Group Plc (NASDAQ:VOD) are up 5.1% to trade at $11.22 this afternoon, following an upgrade to "buy" at BofA Global Research. The stock's options pits are exploding with bullish activity, too, with 15,000 calls across the tape so far -- 15 times the amount typically seen at this point. The most activity is taking place at the April 12 call contract. The bull note comes after a new Group Chief Commercial Officer was announced, and the news also helped VOD cut into its more than 20% year-over-year deficit.

VOD Chart January 122023

After securing a 10-year, multiple-award contract worth $900 million with the U.S. Air Force, BigBear.ai Holdings Inc (NYSE:BBAI) has skyrocketedto the top of New York Stock Exchange (NYSE). The analytics and cyber-engineering company now has the ability to bid and compete as a prime contractor for research and development of new technologies, amongst other deliverables, to the U.S. Air Force. Last seen up 248.7% at $2.95, BBAI is still sports a 38% year-over-year deficit.

Shares of Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) are trading at the very bottom of the Nasdaq, after the biotech company's oral insulin medication failed to meet the primary or secondary endpoints in a Phase 3 clinical trial. ORMP was last seen in penny stock territory, down 75.9% at $2.60. The pullback also pushed Oramed Pharmaceuticals stock below its year-over-year breakeven mark, now down 78.5% in the last 12 months.


Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI